會議議程

講者簡介

 2026/5/2 08:30-11:50  Room 討論室B
  • Workshop-Future of Neurologists
Taiwan (台灣)
  • Kuo-Lun  Huang
  • MD
  • Attending Physician, iBalance Rehabilitation Clinic
    Attending Physician, Taipei Chang Gung Memorial Hospital
    E-mail:drkuolun@gmail.com
Executive Summary:
Dr. Kuo-Lun Huang graduated from College of Medicine, National Cheng-Kung University, and received his neurological residency training in Linkou Chang Gung Memorial Hospital.

Dr. Huang is an associate professor in Linkou Chang Gung Memorial Hospital. His main academic interests include neuroimaging and cognitive studies of vascular and neurodegenerative dementia. He investigated the cognitive changes in patients with carotid artery stenosis with the aid of functional and perfusion MRI, and also investigated the relationship between blood-based biomarkers and neuroimaging biomarkers (amyloid and tau PET scans) in Alzheimer’s disease and related neurodegenerative dementia. In addition to academic interests, Dr. Huang began to practice clinical service in primary rehabilitation clinics, focusing on orthopedic and neuro rehabilitation.
Lecture Abstract:
從醫學中心的嚴謹臨床訓練,到基層診所的第一線服務,神經科醫師如何在不同場域發揮價值?本次講座中,講者將分享過去在腦血管、失智症及神經影像等領域的研究與工作經歷,並談談轉換至基層診所,整合神經內科服務的實戰經驗。誠摯邀請大家一同參與,從學術與臨床的角度,分享神經科醫師於醫學產業的多元發展。

Taiwan (台灣)
  • Chin-Hsien  Lin
  • MD, PhD, Professor
  • 台大醫院神經部教授, 台大醫院神經部
    E-mail:chlin@ntu.edu.tw
Executive Summary:
Dr. Chin-Hsien Lin is Professor of Neurology at National Taiwan University Hospital (NTUH) and a physician-scientist dedicated to unraveling the genetic and molecular mechanisms of Parkinson’s disease (PD) and related neurodegenerative disorders. She earned her M.D. from National Taiwan University, completed neurology residency at NTUH, obtained a Ph.D. from Academia Sinica studying LRRK2 mutations in Drosophila models, and pursued postdoctoral training in translational neuroscience at the University of British Columbia.

Dr. Lin’s research integrates genetic, cellular, and animal model studies with clinical and translational investigations. She explores the molecular pathways of neuronal degeneration, α-synuclein aggregation, and neuroinflammation, and leads one of Asia’s largest longitudinal cohorts of PD and atypical parkinsonism to enable biomarker discovery across genetic, molecular, imaging, and clinical platforms. Her recent work focuses on the gut–brain axis and its contribution to PD pathogenesis, aiming to improve early diagnosis and develop mechanism-based, disease-modifying therapies.

In addition to her research and clinical practice, Dr. Lin serves as Vice Chair of the Department of Medical Research at NTUH. She has held key leadership roles, including President of the Taiwan Movement Disorders Society, and actively contributes to the International Parkinson and Movement Disorder Society (MDS) through the Executive Committee of its Asian and Oceanian Section, the Evidence-Based Medicine Committee, and the Basic Science Committee. Through these efforts, she promotes international collaboration, education, and scientific advancement in movement disorders.
Lecture Abstract:
Conducting research as a physician presents both unique challenges and rewarding opportunities. For many early-career clinicians, the path toward research can seem uncertain, often constrained by time, resources, and competing clinical responsibilities. In this talk, I will share my personal journey of integrating clinical practice with scientific inquiry, from identifying clinically meaningful research questions at the bedside to building collaborative, multidisciplinary teams that can translate ideas into impactful studies. Drawing from experiences in both hospital and academic settings, I will highlight key lessons learned on time management, mentorship, collaboration, and perseverance in the face of setbacks. Practical strategies for balancing patient care with research productivity, securing funding, and fostering international partnerships will also be discussed. Through this personal perspective, I hope to encourage young clinicians to embrace research as an integral part of medical practice and to demonstrate how physician-scientists can bridge the gap between clinical observation and scientific discovery.

Taiwan (台灣)
Executive Summary:
林家億醫師畢業於台北醫學大學醫學系,為中華民國神經科專科醫師,曾任台北榮總及中國醫藥大學台北分院神經內科主治醫師,累積豐富的神經醫學臨床經驗。

其主要臨床專長涵蓋失智症、頭痛疾病及神經系統相關疾患之診斷與長期照護,並關注神經疾病在社區醫療、慢性病管理、長照與居家醫療場域中的整合應用。現任億安醫療體系總院長,致力推動以病人為中心的整合式神經照護,結合實證醫學、預防醫學與跨專業合作,提升基層神經醫療品質。

Dr. Chia-Yi Lin graduated from the School of Medicine at Taipei Medical University and is a board-certified neurologist in Taiwan. He previously served as an attending neurologist at Taipei Veterans General Hospital and China Medical University Taipei Branch Hospital, where he gained extensive clinical experience in neurological medicine.

His primary clinical interests include dementia, headache disorders, and the comprehensive management of neurological diseases. Dr. Lin is currently the Superintendent of the Yi-An Healthcare System and is actively engaged in advancing integrated neurological care across primary care, long-term care, and home-based medical services. His work emphasizes patient-centered, evidence-based neurology, incorporating preventive strategies and chronic disease management to enhance the quality of neurological care in community settings.
Lecture Abstract:
講座內容將聚焦基層神經科發展趨勢,分享診所經營實務與臨床整合經驗,從臨床專業到社區經營,探索神經科醫師在未來醫療環境中的多元定位與實踐路徑。

The lecture will focus on development trends in community-based neurology, sharing practical experience in clinic operations and integrated clinical care.From clinical expertise to community engagement, this lecture explores the diverse roles and practical pathways for neurologists in the evolving healthcare landscape.

Taiwan (台灣)
Executive Summary:
Cheng-Yang Hsieh, MD, PhD is a board-certified neurologist at Tainan Sin Lau Hospital and an adjunct assistant professor at National Cheng Kung University. He is an active member of the Board of Directors of the Taiwan Stroke Society, contributing to national guideline development and academic exchange. Dr. Hsieh’s research focuses on stroke prevention, real-world evidence, and health policy, with numerous publications in leading international journals.

In recognition of his contributions, he was named among the World’s Top 2% Scientists by Stanford University and Elsevier in both 2024 and 2025, and was honored as an Outstanding Alumnus of the National Cheng Kung University College of Medicine in 2023. Balancing clinical practice with research and education, Dr. Hsieh is committed to improving stroke care in Taiwan and fostering international collaboration in cerebrovascular medicine.
Lecture Abstract:
Being a hospital-based neurologist is both a privilege and a challenge. The joys come from those moments when a timely diagnosis and acute intervention change the trajectory of a patient’s life, and from contributing to scientific knowledge that advances stroke prevention and care. Yet, the sorrows are equally present—long nights on call in the ward, the relentless pressure of responding to stroke codes in the emergency department, and the emotional toll of making critical decisions under time constraints. These experiences highlight not only the intensity of neurological care but also the human cost borne by both patients and physicians. Drawing on my experiences in stroke care, guideline development, and real-world data research, I will reflect on how to balance clinical duties with academic growth, and how to sustain motivation in the face of systemic burdens. Finally, I will share suggestions for the younger generation of neurologists: how to navigate the medical system and advocate for one’s own rights, how to protect oneself from the disruptions of medical disputes, and how to manage personal finance and investments wisely so that clinical work can be pursued with fewer worries. My hope is that these reflections will resonate with colleagues and inspire collective efforts to improve both the science and humanity of neurology.

Taiwan (台灣)
  • Kai-Cheng  Hsu
  • MD, PhD, MSc, Assistant Professor
  • 總經理, 宏碁智醫
    E-mail:edwardfirst@gmail.com
Executive Summary:
許凱程醫師為神經科主治醫師,專長為失智症、腦中風與睡眠障礙治療;台大醫學系畢業後,致力於醫學與工程的跨領域結合,在工程方面取得國立中正大學化學工程博士與電機工程碩士,並於2018-2020赴美國國家衛生研究院的神經與腦中風機構,訊息與生物資訊部門擔任研究員。專長為人工智慧、系統生物學、生醫訊號處理與生物資訊學。許醫師有豐富的醫療人工智慧實作經驗,能夠結合臨床知識與人工智慧技術,提升AI在臨床醫療之應用。2020-2023擔任中國醫藥大學附設醫院人工智慧中心主任,領導該中心開發多項AI工具,於臨床上線使用,且取得TFDA智慧醫材認證,並已有多篇醫療人工智慧學術論文發表。2024年加入工業技術研究院,進一步從事健康醫療產業領域的AI研究,包括人工智慧在醫學影像、生物醫學信號、電子病歷和生物資訊學的應用。2025年4月起,擔任宏碁智醫總經理兼醫療長,推動智慧醫療技術之臨床落地與產業化。
Lecture Abstract:
Neurology is one of the most interdisciplinary fields in medicine, requiring integration of clinical knowledge with data from imaging, electrophysiology, and genomics. Artificial intelligence (AI) has become a powerful catalyst to bridge these domains, enabling neurologists to translate complex data into actionable insights for both patient care and research. My professional journey reflects this spirit of cross-disciplinary learning and innovation. With formal training in medicine, electrical engineering, and chemical engineering, I have pursued research that combines systems biology, computational optimization, and clinical neurology. This work has led to AI-based methods for seizure detection from EEG, identification of therapeutic targets in Parkinson’s disease, and biomarker discovery using advanced modeling. These experiences illustrate how engineering and computational thinking can open new possibilities in neurological research. Clinically, AI applications are already demonstrating value: assisting in the early detection of stroke and dementia, automating medical documentation, and supporting timely, precise decision-making. Beyond these immediate gains, generative AI and disease “digital twins” are emerging as tools to simulate disease trajectories, optimize interventions, and accelerate clinical trials. The future of AI in neurology will depend not only on technology but on cultivating interdisciplinary collaboration among clinicians, engineers, and data scientists. By embracing cross-domain learning and research, we can transform neurology into a field that is more predictive, preventive, and patient-centered—delivering impact both at the bedside and across the healthcare system.

Taiwan (台灣)
  • Li-Kai  Tsai
  • MD, PhD
  • Attending Physician, National Taiwan University Hospital
    Professor, National Taiwan University College of Medicine
    E-mail:009502@ntuh.gov.tw
Executive Summary:
Dr. Li-Kai Tsai was born in Tainan, Taiwan. He graduated from National Taiwan University (NTU) with MD degree in 1999 and was trained as a Neurologist in the NTU Hospital. He got the license of Neurologist in 2003 and had a short-term research program about stem cell therapy in National Institutes of Health, United States in 2009-2010. He got a PhD degree in 2010 from the Institute of Clinical Medicine, NTU. He is now a Professor at NTU. His interest is in research of motor neuron diseases and cerebrovascular diseases. Dr. Tsai has authored more than 190 peer-reviewed papers on his research work, which has led to major publications in Brain, Annals of Neurology, Neurology, Stroke, Journal of Stroke, Journal of Cachexia, Sarcopenia & Muscle, and Brain Communication, etc. He is now the Secretary General of Taiwan Neurological Society, an Editor-in-Chief of the Formosan Journal of Stroke and an Executive Editor of the Acta Neurological Taiwanica.
Lecture Abstract:
With advanced progress of neurological diagnosis and therapy, the clinical load increases year by year for neurologists in Taiwan. Although novel treatment provides new hope for patients with neurological diseases and creates attractive research topics in neuroscience, it also impacts the quality of life of our residents and attending physician on the first-line clinical practice. Recently, the Taiwan Neurological Society has investigated the current problems and potential solutions from our members and developed a thorough plan to overcome this challenge. It includes 5 sections of programs: (1) Improve the quality of neurological education and encourage research: Returning to the original intention of choosing neurology; (2) Strive for reasonable health insurance reimbursements to ensure fairness in business compensation: equitable payment for hard work; (3) Reduce the workload of neurologists and improve administrative efficiency: Diminish overwork; (4) Enhancing the value and professional role of neurologists: Emphasizing professional value; and (5) Improving the local clinics environment for neurology: Providing diverse pathways and facilitating patient triage to local clinics settings. During the meeting, any constructive suggestion is highly appreciated to improve our neurological field. Let us work together to face and reverse the current difficult neurological environment in Taiwan.